Healthcare | August 10, 2021
Merck launches New Pergoveris Pen for fertility treatment in India
A globally approved pen filled by mass technology provides a safer self- administration fertility solution
A globally approved pen filled by mass technology provides a safer self- administration fertility solution
Nexviazyme specifically targets the M6P receptor, the key pathway for enzyme replacement therapy, to effectively clear glycogen build-up in muscle cells
PegIFN in COVID19 has several add-on advantages compared to other anti-viral agents
Droxidopa Capsules, 100 mg, 200 mg, and 300 mg, are indicated for the treatment of orthostatic dizziness
Subscribe To Our Newsletter & Stay Updated
